These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8097861)

  • 1. Etonitazene: an opioid selective for the mu receptor types.
    Moolten MS; Fishman JB; Chen JC; Carlson KR
    Life Sci; 1993; 52(18):PL199-203. PubMed ID: 8097861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipodal alpha-N-(methyl through decyl)-N-normetazocines (5,9 alpha-dimethyl-2'-hydroxy-6,7-benzomorphans): in vitro and in vivo properties.
    May EL; Aceto MD; Bowman ER; Bentley C; Martin BR; Harris LS; Medzihradsky F; Mattson MV; Jacobson AE
    J Med Chem; 1994 Sep; 37(20):3408-18. PubMed ID: 7932569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The mu, delta and kappa properties of various opioids].
    Ohta S; Niwa M; Nozaki M; Hattori M; Shimonaka H; Dohi S
    Masui; 1995 Sep; 44(9):1228-32. PubMed ID: 8523655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
    Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
    Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Affinity profiles of morphine, codeine, dihydrocodeine and their glucuronides at opioid receptor subtypes.
    Mignat C; Wille U; Ziegler A
    Life Sci; 1995; 56(10):793-9. PubMed ID: 7885194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective protection and functionalization of morphine: synthesis and opioid receptor binding properties of 3-amino-3-desoxymorphine derivatives.
    Wentland MP; Duan W; Cohen DJ; Bidlack JM
    J Med Chem; 2000 Sep; 43(19):3558-65. PubMed ID: 11000010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of mu, kappa, and delta opioid binding in amphibian whole brain tissue homogenates.
    Newman LC; Sands SS; Wallace DR; Stevens CW
    J Pharmacol Exp Ther; 2002 Apr; 301(1):364-70. PubMed ID: 11907194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
    Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
    Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cloned mu, delta and kappa receptors and their endogenous ligands: evidence for two opioid peptide recognition cores.
    Mansour A; Hoversten MT; Taylor LP; Watson SJ; Akil H
    Brain Res; 1995 Nov; 700(1-2):89-98. PubMed ID: 8624732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mu1, mu2, delta, kappa opioid receptor binding profiles of methadone stereoisomers and morphine.
    Kristensen K; Christensen CB; Christrup LL
    Life Sci; 1995; 56(2):PL45-50. PubMed ID: 7823756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM; Qian X; Schiller PW; Szeto HH
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.
    May EL; Jacobson AE; Mattson MV; Traynor JR; Woods JH; Harris LS; Bowman ER; Aceto MD
    J Med Chem; 2000 Dec; 43(26):5030-6. PubMed ID: 11150174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic Characterization of Substituted Nitazenes at
    Kozell LB; Eshleman AJ; Wolfrum KM; Swanson TL; Bloom SH; Benware S; Schmachtenberg JL; Schutzer KA; Schutzer WE; Janowsky A; Abbas AI
    J Pharmacol Exp Ther; 2024 Apr; 389(2):219-228. PubMed ID: 38453524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphine-6beta-glucuronide and morphine-3-glucuronide, opioid receptor agonists with different potencies.
    Ulens C; Baker L; Ratka A; Waumans D; Tytgat J
    Biochem Pharmacol; 2001 Nov; 62(9):1273-82. PubMed ID: 11705461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding affinity and selectivity of opioids at mu, delta and kappa receptors in monkey brain membranes.
    Emmerson PJ; Liu MR; Woods JH; Medzihradsky F
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1630-7. PubMed ID: 7996478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.
    Neilan CL; Husbands SM; Breeden S; Ko MC; Aceto MD; Lewis JW; Woods JH; Traynor JR
    Eur J Pharmacol; 2004 Sep; 499(1-2):107-16. PubMed ID: 15363957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing agonist potency and selectivity for the opioid delta receptor are revealed in structure-activity relationship studies of the 4-[(N-substituted-4-piperidinyl)arylamino]-N,N-diethylbenzamides.
    Thomas JB; Herault XM; Rothman RB; Atkinson RN; Burgess JP; Mascarella SW; Dersch CM; Xu H; Flippen-Anderson JL; George CF; Carroll FI
    J Med Chem; 2001 Mar; 44(6):972-87. PubMed ID: 11300879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
    Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
    J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.